CRISPR Therapeutics (NASDAQ:CRSP) used a fireside chat at TD Cowen’s 46th Annual Healthcare Conference to outline how the ...

(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, announced a commercial partnership with ClearCardio (TM), a leading preventive ...

VDyne Inc. ("VDyne"), a privately held medical device company developing a transcatheter tricuspid valve replacement (TTVR) ...

The company's platform integrates genomic sequencing, clinical data analytics, and AI-driven insights across oncology, cardiology, and neuropsychiatry. Tempus serves more than 50% of U.S. oncologists ...

Agreement Combines Tenaya’s Expertise in Identification and Validation ofGenetic Heart Disease Targets with Alnylam’s Ability to Deliver ...

Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and ...

Georgia Tech has been awarded up to $21.8 million from the Advanced Research Projects Agency for Health (ARPA-H) to develop a first-of-its-kind therapy for lymphatic disease, a condition that has long ...

Medical professionals raise concerns over prolonged radiation exposure in heart procedures. Proposals for enhanced protection systems are met with opposition.

More than one-quarter of pediatric patients on ventricular assist devices were able to have their devices explanted due to a ...

The Georgia Institute of Technology has been awarded up to $21.8 million from the Advanced Research Projects Agency for Health (ARPA-H) to deliver a first-of-its-kind therapy to patients with ...

Platform integrates with major wearables and fitness apps to deliver AI-powered health insights, advanced HRV metrics, ...

Lohman Technologies ( innovator of the FDA-cleared HomECG+ medical-grade home ECG monitoring device, today announced a deepened strategic partnership with Salvo Health ( a leading virtual care ...